KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Total Debt (2020 - 2025)

Historic Total Debt for Fulgent Genetics (FLGT) over the last 6 years, with Q3 2025 value amounting to $30.5 million.

  • Fulgent Genetics' Total Debt rose 361.1% to $30.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.5 million, marking a year-over-year increase of 361.1%. This contributed to the annual value of $30.1 million for FY2024, which is 1729.66% up from last year.
  • Per Fulgent Genetics' latest filing, its Total Debt stood at $30.5 million for Q3 2025, which was up 361.1% from $29.6 million recorded in Q2 2025.
  • Over the past 5 years, Fulgent Genetics' Total Debt peaked at $51.2 million during Q2 2021, and registered a low of $14.5 million during Q2 2023.
  • In the last 5 years, Fulgent Genetics' Total Debt had a median value of $28.8 million in 2024 and averaged $26.7 million.
  • Its Total Debt has fluctuated over the past 5 years, first crashed by 5006.73% in 2023, then soared by 9910.1% in 2024.
  • Over the past 5 years, Fulgent Genetics' Total Debt (Quarter) stood at $19.8 million in 2021, then decreased by 7.25% to $18.4 million in 2022, then skyrocketed by 39.7% to $25.7 million in 2023, then rose by 17.3% to $30.1 million in 2024, then rose by 1.32% to $30.5 million in 2025.
  • Its last three reported values are $30.5 million in Q3 2025, $29.6 million for Q2 2025, and $29.7 million during Q1 2025.